These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 15680406)
1. Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer. Ripa RS; Katballe N; Wikman FP; Jäger AC; Bernstein I; Orntoft T; Schwartz M; Nielsen FC; Bisgaard ML Mutat Res; 2005 Feb; 570(1):89-96. PubMed ID: 15680406 [TBL] [Abstract][Full Text] [Related]
2. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer. Froggatt NJ; Green J; Brassett C; Evans DG; Bishop DT; Kolodner R; Maher ER J Med Genet; 1999 Feb; 36(2):97-102. PubMed ID: 10051005 [TBL] [Abstract][Full Text] [Related]
3. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC). Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318 [TBL] [Abstract][Full Text] [Related]
4. Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC. Stella A; Surdo NC; Lastella P; Barana D; Oliani C; Tibiletti MG; Viel A; Natale C; Piepoli A; Marra G; Guanti G Clin Genet; 2007 Feb; 71(2):130-9. PubMed ID: 17250661 [TBL] [Abstract][Full Text] [Related]
5. [Recognising hereditary non-polyposis colorectal cancer without a clear family history]. de Bruin JH; Nagengast FM; Ligtenberg MJ; van Krieken JH; Niermeijer MF; Hoogerbrugge N Ned Tijdschr Geneeskd; 2004 Oct; 148(42):2053-7. PubMed ID: 15532325 [TBL] [Abstract][Full Text] [Related]
6. Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes. Huang RL; Chao CF; Ding DC; Yu CP; Chang CC; Lai HC; Yu MH; Liu HS; Chu TY Cancer Genet Cytogenet; 2004 Sep; 153(2):108-14. PubMed ID: 15350299 [TBL] [Abstract][Full Text] [Related]
7. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy. Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463 [TBL] [Abstract][Full Text] [Related]
8. Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype. Pérez-Cabornero L; Borrás Flores E; Infante Sanz M; Velasco Sampedro E; Acedo Becares A; Lastra Aras E; Cuevas González J; Pineda Riu M; Ramón y Cajal Asensio T; Capellá Munar G; Miner Pino C; Durán Domínguez M Cancer Prev Res (Phila); 2011 Oct; 4(10):1546-55. PubMed ID: 21778331 [TBL] [Abstract][Full Text] [Related]
9. Functional analysis of HNPCC-related missense mutations in MSH2. Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302 [TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree. Ponz de Leon M; Benatti P; Percesepe A; Rossi G; Viel A; Santarosa M; Pedroni M; Roncucci L Ital J Gastroenterol Hepatol; 1999; 31(6):476-80. PubMed ID: 10575566 [TBL] [Abstract][Full Text] [Related]
11. New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife. Medina-Arana V; Barrios Y; Fernández-Peralta A; Herrera M; Chinea N; Lorenzo N; Jiménez A; Martín-López JV; González-Hermoso F; Salido E; González-Aguilera JJ Cancer Lett; 2006 Dec; 244(2):268-73. PubMed ID: 16500024 [TBL] [Abstract][Full Text] [Related]
12. [Need of new clinical criteria for the identification of genetic Lynch syndrome]. Sousa R; Lage P; Ferreira S; Claro I; Francisco I; Filipe B; Albuquerque C; Suspiro A; Rodrigues P; Nobre-Leitão C Acta Med Port; 2007; 20(6):535-42. PubMed ID: 18331697 [TBL] [Abstract][Full Text] [Related]
13. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients. Steinke V; Rahner N; Morak M; Keller G; Schackert HK; Görgens H; Schmiegel W; Royer-Pokora B; Dietmaier W; Kloor M; Engel C; Propping P; Aretz S; Eur J Hum Genet; 2008 May; 16(5):587-92. PubMed ID: 18301448 [TBL] [Abstract][Full Text] [Related]
14. Hereditary nonpolyposis colorectal cancer: pitfalls in deletion screening in MSH2 and MLH1 genes. Wehner M; Mangold E; Sengteller M; Friedrichs N; Aretz S; Friedl W; Propping P; Pagenstecher C Eur J Hum Genet; 2005 Aug; 13(8):983-6. PubMed ID: 15870828 [TBL] [Abstract][Full Text] [Related]
15. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene. Banville N; Geraghty R; Fox E; Leahy DT; Green A; Keegan D; Geoghegan J; O'Donoghue D; Hyland J; Sheahan K Hum Pathol; 2006 Nov; 37(11):1498-502. PubMed ID: 16996571 [TBL] [Abstract][Full Text] [Related]
16. Novel germline hMSH2 genomic deletion and somatic hMSH2 mutations in a hereditary nonpolyposis colorectal cancer family. Miyaki M; Iijima T; Yamaguchi T; Shirahama S; Ito T; Yasuno M; Mori T Mutat Res; 2004 Apr; 548(1-2):19-25. PubMed ID: 15063132 [TBL] [Abstract][Full Text] [Related]
17. Founder effect of a pathogenic MSH2 mutation identified in Spanish families with Lynch syndrome. Menéndez M; Castellví-Bel S; Pineda M; de Cid R; Muñoz J; González S; Teulé A; Balaguer F; Ramón y Cajal T; Reñé JM; Blanco I; Castells A; Capellà G Clin Genet; 2010 Aug; 78(2):186-90. PubMed ID: 20095990 [TBL] [Abstract][Full Text] [Related]
18. A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma. Hirata K; Kanemitsu S; Nakayama Y; Nagata N; Itoh H; Ohnishi H; Ishikawa H; Furukawa Y; Am J Gastroenterol; 2006 Jan; 101(1):193-6. PubMed ID: 16405554 [TBL] [Abstract][Full Text] [Related]
19. Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. Roncari B; Pedroni M; Maffei S; Di Gregorio C; Ponti G; Scarselli A; Losi L; Benatti P; Roncucci L; De Gaetani C; Camellini L; Lucci-Cordisco E; Tricarico R; Genuardi M; Ponz de Leon M Clin Genet; 2007 Sep; 72(3):230-7. PubMed ID: 17718861 [TBL] [Abstract][Full Text] [Related]
20. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor. Plaschke J; Linnebacher M; Kloor M; Gebert J; Cremer FW; Tinschert S; Aust DE; von Knebel Doeberitz M; Schackert HK Eur J Hum Genet; 2006 May; 14(5):561-6. PubMed ID: 16418736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]